Quick answers
- What is Humalog KwikPen?
- Humalog KwikPen is a brand name of Insulin lispro, a prescription medicine. The FDA NDC Directory lists 4 Humalog KwikPen products in 2 strengths and forms.
- Who makes Humalog KwikPen?
- Lilly holds the FDA application for Humalog KwikPen (BLA020563, approved June 14, 1996). 1 other company (repackagers or distributors) also list Humalog KwikPen products.
- Is there a generic or store brand of Humalog KwikPen?
- Yes. The FDA NDC Directory lists 21 other products with the same active ingredients, strength and form as a Humalog KwikPen product. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Humalog KwikPen?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 2 Humalog KwikPen strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Humalog KwikPen been recalled?
- FDA enforcement reports list 2 recalls of Humalog KwikPen products; the newest started March 12, 2024. A recall usually concerns specific lots, not every product.
What Humalog KwikPen is
Each Humalog KwikPen product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Insulin lispro · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| insulin lispro 100 units/mL injection, solution (intravenous, subcutaneous) | Humalog KwikPen | 20 products, 4 companies | DailyMed |
| insulin lispro 200 units/mL injection, solution (subcutaneous) | Humalog KwikPen | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Insulin lispro →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| insulin lispro 100 units/mL injection, solution | Brand: Humalog KwikPen | $10.16 per mL Generic of the same strength and form: $2.40–$10.19 per mL |
| insulin lispro 200 units/mL injection, solution | Brand: Humalog KwikPen | $20.31 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Humalog KwikPen
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Humalog KwikPen products.
- A-S Medication Solutions2 products
- Eli Lilly and Company2 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 12, 2024 · Class II · Completed · D-0445-2024
CGMP Deviations
Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, I — Eli Lilly & Company
-
April 5, 2022 · Class I · Completed · D-0882-2022
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59 — Cardinal Health Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.